275 related articles for article (PubMed ID: 9952373)
1. Effective phagocytosis and killing of Candida albicans via targeting FcgammaRI (CD64) or FcalphaRI (CD89) on neutrophils.
van Spriel AB; van den Herik-Oudijk IE; van Sorge NM; Vilé HA; van Strijp JA; van de Winkel JG
J Infect Dis; 1999 Mar; 179(3):661-9. PubMed ID: 9952373
[TBL] [Abstract][Full Text] [Related]
2. Generation of HER-2/neu-specific cytotoxic neutrophils in vivo: efficient arming of neutrophils by combined administration of granulocyte colony-stimulating factor and Fcgamma receptor I bispecific antibodies.
Heijnen IA; Rijks LJ; Schiel A; Stockmeyer B; van Ojik HH; Dechant M; Valerius T; Keler T; Tutt AL; Glennie MJ; van Royen EA; Capel PJ; van de Winkel JG
J Immunol; 1997 Dec; 159(11):5629-39. PubMed ID: 9548506
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of polymorphonuclear cell-mediated tumor cell killing on simultaneous engagement of fcgammaRI (CD64) and fcalphaRI (CD89).
van Egmond M; van Spriel AB; Vermeulen H; Huls G; van Garderen E; van de Winkel JG
Cancer Res; 2001 May; 61(10):4055-60. PubMed ID: 11358825
[TBL] [Abstract][Full Text] [Related]
4. FcalphaRI (CD89) as a novel trigger molecule for bispecific antibody therapy.
Valerius T; Stockmeyer B; van Spriel AB; Graziano RF; van den Herik-Oudijk IE; Repp R; Deo YM; Lund J; Kalden JR; Gramatzki M; van de Winkel JG
Blood; 1997 Dec; 90(11):4485-92. PubMed ID: 9373259
[TBL] [Abstract][Full Text] [Related]
5. Monocyte-mediated lysis of acute myeloid leukemia cells in the presence of the bispecific antibody 251 x 22 (anti-CD33 x anti-CD64).
Chen J; Zhou JH; Ball ED
Clin Cancer Res; 1995 Nov; 1(11):1319-25. PubMed ID: 9815927
[TBL] [Abstract][Full Text] [Related]
6. Targeting of Porphyromonas gingivalis with a bispecific antibody directed to FcalphaRI (CD89) improves in vitro clearance by gingival crevicular neutrophils.
Kobayashi T; Takauchi A; van Spriel AB; Vilé HA; Hayakawa M; Shibata Y; Abiko Y; van de Winkel JG; Yoshie H
Vaccine; 2004 Dec; 23(5):585-94. PubMed ID: 15542178
[TBL] [Abstract][Full Text] [Related]
7. Modulation of neutrophil-mediated activity against the pseudohyphal form of Candida albicans by granulocyte colony-stimulating factor (G-CSF) administered in vivo.
Gaviria JM; van Burik JA; Dale DC; Root RK; Liles WC
J Infect Dis; 1999 May; 179(5):1301-4. PubMed ID: 10191242
[TBL] [Abstract][Full Text] [Related]
8. Triggering Fc alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy.
Stockmeyer B; Dechant M; van Egmond M; Tutt AL; Sundarapandiyan K; Graziano RF; Repp R; Kalden JR; Gramatzki M; Glennie MJ; van de Winkel JG; Valerius T
J Immunol; 2000 Nov; 165(10):5954-61. PubMed ID: 11067958
[TBL] [Abstract][Full Text] [Related]
9. Preclinical studies with Fc(gamma)R bispecific antibodies and granulocyte colony-stimulating factor-primed neutrophils as effector cells against HER-2/neu overexpressing breast cancer.
Stockmeyer B; Valerius T; Repp R; Heijnen IA; Bühring HJ; Deo YM; Kalden JR; Gramatzki M; van de Winkel JG
Cancer Res; 1997 Feb; 57(4):696-701. PubMed ID: 9044847
[TBL] [Abstract][Full Text] [Related]
10. Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens.
Gaviria JM; van Burik JA; Dale DC; Root RK; Liles WC
J Infect Dis; 1999 Apr; 179(4):1038-41. PubMed ID: 10068606
[TBL] [Abstract][Full Text] [Related]
11. Effective targeting of pathogens to neutrophils via chimeric surfactant protein D/anti-CD89 protein.
Tacken PJ; Hartshorn KL; White MR; van Kooten C; van de Winkel JG; Reid KB; Batenburg JJ
J Immunol; 2004 Apr; 172(8):4934-40. PubMed ID: 15067073
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of G-CSF- or GM-CSF-stimulated tumor cell killing by Fc receptor-directed bispecific antibodies.
Stockmeyer B; Elsässer D; Dechant M; Repp R; Gramatzki M; Glennie MJ; van de Winkel JG; Valerius T
J Immunol Methods; 2001 Feb; 248(1-2):103-11. PubMed ID: 11223072
[TBL] [Abstract][Full Text] [Related]
13. Bispecific molecules directed to the Fc receptor for IgA (Fc alpha RI, CD89) and tumor antigens efficiently promote cell-mediated cytotoxicity of tumor targets in whole blood.
Deo YM; Sundarapandiyan K; Keler T; Wallace PK; Graziano RF
J Immunol; 1998 Feb; 160(4):1677-86. PubMed ID: 9469424
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin A-mediated protection against Bordetella pertussis infection.
Hellwig SM; van Spriel AB; Schellekens JF; Mooi FR; van de Winkel JG
Infect Immun; 2001 Aug; 69(8):4846-50. PubMed ID: 11447159
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil Fc gamma RI as target for immunotherapy of invasive candidiasis.
van Spriel AB; van den Herik-Oudijk IE; van de Winkel JG
J Immunol; 2001 Jun; 166(12):7019-22. PubMed ID: 11390445
[TBL] [Abstract][Full Text] [Related]
16. Enhanced phagocytosis and intracellular killing of Candida albicans by GM-CSF-activated human neutrophils.
Richardson MD; Brownlie CE; Shankland GS
J Med Vet Mycol; 1992; 30(6):433-41. PubMed ID: 1287162
[TBL] [Abstract][Full Text] [Related]
17. Evaluating antibodies for their capacity to induce cell-mediated lysis of malignant B cells.
Würflein D; Dechant M; Stockmeyer B; Tutt AL; Hu P; Repp R; Kalden JR; van de Winkel JG; Epstein AL; Valerius T; Glennie M; Gramatzki M
Cancer Res; 1998 Jul; 58(14):3051-8. PubMed ID: 9679970
[TBL] [Abstract][Full Text] [Related]
18. Antitumor immune effector mechanisms recruited by phage display-derived fully human IgG1 and IgA1 monoclonal antibodies.
Huls G; Heijnen IA; Cuomo E; van der Linden J; Boel E; van de Winkel JG; Logtenberg T
Cancer Res; 1999 Nov; 59(22):5778-84. PubMed ID: 10582699
[TBL] [Abstract][Full Text] [Related]
19. Targeting to Fcgamma receptors, but not CR3 (CD11b/CD18), increases clearance of Bordetella pertussis.
Hellwig SM; van Oirschot HF; Hazenbos WL; van Spriel AB; Mooi FR; van De Winkel JG
J Infect Dis; 2001 Mar; 183(6):871-9. PubMed ID: 11237803
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte-colony stimulating factor enhances chimeric antibody Nd2 dependent cytotoxicity against pancreatic cancer mediated by polymorphonuclear neutrophils.
Tamamori Y; Sawada T; Nishihara T; Yamashita Y; Ohira M; Ho JJ; Kim YS; Hirakawa-Y S Chung K
Int J Oncol; 2002 Sep; 21(3):649-54. PubMed ID: 12168113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]